Shruti Gohil, IDSI Co-Director, School of Medicine
Early in the pandemic when testing was limited and the prevalence of COVID-19 was unknown, public health recommendations restricted testing for individuals at high risk for COVID-19. Risk factors included travel history, symptoms, and close contact with someone who had a history of COVID-19. As the access to testing expanded and concerns for asymptomatic transmission mounted, healthcare facilities broadened COVID-19 surveillance strategies to include testing for all asymptomatic patients requiring hospital admission or aerosol-generating procedures. Read the Article on Pubmed.
